Open access · CC-BY
via OpenAlex
Resveratrol analog, triacetylresveratrol, a potential immunomodulator of lung adenocarcinoma immunotherapy combination therapies
Jian He, Nianxiang Qiu, Xianchao Zhou, Mei Meng, Zixue Liu, Jingquan Li, Shiyu Du, Zhiqiang Sun, Hui Wang
Frontiers in Oncology · 2023 · ▲ 11 citations
Abstract
Introduction: Resveratrol, an activator for longevity regulatory genes-sirtuin family (SIRTs) and Sirtuin 2 (SIRT2) is an important factor of SIRTs which demonstrated biological function in cancers, but the underlying mechanism is unrevealed. Methods: We investigated the mRNA and protein levels of SIRT2 in a variety of cancers and the potential role for clinical prognosis, as well as analysed the association between the gene and immune infiltration in various cancers. And an analysis of two types of lung cancer was conducted to construct a systematic prognostic landscape. Finally, putative binding site of the triacetylresveratrol bound to SIRT2 was built from homology modeling. Results and discussion: We concluded that higher mRNA and protein levels of SIRT2 affected prognosis in various types of cancers, especially in LUAD cohorts. In addition, SIRT2 is linked with a better overall survival (OS) in LUAD patients. Further research suggested a possible explanation for this phenotype might be that SIRT2 mRNA levels are positively correlated with infiltrating status of multiple immunocytes in LU-AD but not LUSC, i.e. SIRT2 expression may contribute to the recruitment of CD8+T cell, CD4+ T cell, T cell CD4+ memory resting, Tregs, T cell NK and positively correlated to the expression of PD-1, also excluding neutrophil, T cell CD8+ naïve and B cell plasma cells in LUAD. We found that triacetyl-resveratrol demonstrated the most potent agonist efficiency to SIRT2 and the EC 50 as low as 142.79 nM. As a result, SIRT2 appears to be a promising novel biomarker for prognosis prediction in patients with LUAD and triacetylresveratrol might be a potential immunomodulator of LUAD to anti-PD-1 based immunotherapy combination therapies.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3389/fonc.2022.1007653
- Canonical
- link ↗
- Fetched
- 2026-11-08 MST
Cite this
APA
He, J., Qiu, N., Zhou, X., Meng, M., Liu, Z., Li, J., Du, S., Sun, Z., & Wang, H. (2023). Resveratrol analog, triacetylresveratrol, a potential immunomodulator of lung adenocarcinoma immunotherapy combination therapies. <em>Frontiers in Oncology</em>. https://doi.org/10.3389/fonc.2022.1007653
Vancouver
He J, Qiu N, Zhou X, Meng M, Liu Z, Li J, et al. Resveratrol analog, triacetylresveratrol, a potential immunomodulator of lung adenocarcinoma immunotherapy combination therapies. Frontiers in Oncology. 2023. doi:10.3389/fonc.2022.1007653.
BibTeX
@article{jian2023Resver,
title = {Resveratrol analog, triacetylresveratrol, a potential immunomodulator of lung adenocarcinoma immunotherapy combination therapies},
author = {Jian He and Nianxiang Qiu and Xianchao Zhou and Mei Meng and Zixue Liu and Jingquan Li and Shiyu Du and Zhiqiang Sun and Hui Wang},
journal = {Frontiers in Oncology},
year = {2023},
doi = {10.3389/fonc.2022.1007653},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Smart Medicine 2022
Open access · CC-BY
Reprogramming stem cells in regenerative medicine
Institut Català d'Oncologia 2021
Open access · US-GOV
Impact of Body Composition on the Prognosis and Toxicity of Patients Diagnosed With Recurrence or Metastasic Squamous Cell Carcinoma of the Head and Neck (SCCHN) Treated With Immune Checkpoint Inhibitors (ICI)
Endocrine 2026
Open access · OA
Thyroid hormone deprivation creates an immunological signature in the mouse liver, involving Kupffer cell presentation as the mouse ages.
International Journal of Molecular Sciences 2024
Open access · CC-BY
Various Strategies of Tendon Stem/Progenitor Cell Reprogramming for Tendon Regeneration
Pharmaceuticals 2023
Open access · CC-BY
Anticancer Potential of Flavonoids: An Overview with an Emphasis on Tangeretin
EBioMedicine 2019
Open access · CC-BY